Advertisement
Screener

Sintx Technologies, Inc. (SINT) Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted

1.4 / 5 stars · 27/98 Roast Me

Sintx Technologies, Inc. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted

Sintx Technologies, Inc. (SINT) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of -$6.14 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.

Discontinued › Income Statement › Other Income

us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2020-03-26

  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2019-12-31 was -$1.58M.
  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2019-09-30 was -$1.59M.
  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2019-06-30 was -$1.36M.
  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2019-03-31 was -$1.61M.
  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2019 was -$6.14M.
  • Sintx Technologies, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2018 was -$16.59M.
Period endNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month as first filed
2019-12-31-$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
-$3.17M
derived: sum of 2 quarters · filed 2020-03-26
-$4.54M
derived: sum of 3 quarters · filed 2020-03-26
-$6.14M
10-K · filed 2020-03-26
2019-09-30-$1.59M
10-Q · filed 2019-11-13
-$2.95M
derived: sum of 2 quarters · filed 2019-11-13
-$4.56M
10-Q · filed 2019-11-13
-$6.12M
derived: sum of 4 quarters · filed 2020-03-26
2019-06-30-$1.36M
10-Q · filed 2019-08-14
-$2.97M
10-Q · filed 2019-08-14
-$4.53M
derived: sum of 3 quarters · filed 2020-03-26
-$11.98M
derived: sum of 4 quarters · filed 2020-03-26
2019-03-31-$1.61M
derived: 10-K 12 month − 3 quarters · filed 2020-03-26
-$3.16M
derived: sum of 2 quarters · filed 2020-03-26
-$10.62M
derived: sum of 3 quarters · filed 2020-03-26
-$14.41M
derived: sum of 4 quarters · filed 2020-03-26
2018-12-31-$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
-$9.01M
derived: sum of 2 quarters · filed 2020-03-26
-$12.80M
derived: sum of 3 quarters · filed 2020-03-26
-$16.59M
10-K · filed 2020-03-26
-$16.59K
10-K · filed 2019-03-11
2018-09-30-$7.45M
10-Q · filed 2019-11-13
-$11.24M
derived: sum of 2 quarters · filed 2019-11-13
-$15.03M
10-Q · filed 2019-11-13
2018-06-30-$3.79M
10-Q · filed 2019-08-14
-$6.03M
10-Q · filed 2019-08-14
2018-03-31-$3.80M
10-Q · filed 2019-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01
CERENOME, INC. (CNSY)United States$0.014B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B